Our Blog

Posts Categorized: Treatments

What Are These Terrible Drugs I Have To Take?

Published On: |Eric Brown

Antiestrogen medications are commonly used in the treatment of breast cancer.  It is amazing just how many women discontinue this treatemnt due to ‘side effects’.  The ‘power’ of these drugs cannot be overestimated … in many case, their effectiveness is more than chemotherapy. Below is an summary (taken directly from the Journal of Clinical Pathways) […]

Learn More

Margins … Ugh!

Published On: |Eric Brown

Complete excision of breast cancer is the goal of surgery.  Obtaining clear, microscopic margins can be a challenge.  Having involved margins occurs in 25-30% of cases, thus requiring a second operation (re-excision).  The challenge is not based on the technical aspects of surgery, but the fact that disease as a margin is most often microscopic; […]

Learn More

“Thanks A Lot, Now I’m In Menopause!”

Published On: |Eric Brown

There are many aspects of breast cancer therapy that can result win menopausal symptoms during and after treatment.  In fact, in some studies pre-menopausal women who do not recover ovarian function if lost during her treatment, actually fair BETTER than women who do.  Estrogen blockade, either by blocking the estrogen receptor or its production, are […]

Learn More

Major Advances In Breast Cancer 2014

Published On: |Eric Brown

As 2014 came to an end, just like the years “Top Plays” seen on ESPN, there have been major advances in the care of breast cancer patients.   So, here is a list of our “Top Plays”:   MARGINS – “no ink on tumor” has become the standard for clear margins for invasive breast cancer.  What […]

Learn More

Multidisciplinary Care

Published On: |Eric Brown

Breast cancer is the most common cancer in women.  As Director of the Center for Breast Health, at the Troy Campus of Beaumont Health, Dr. Brown works intimately with the Beaumont Cancer Institute in developing a streamlined approach to the care of the Breast Cancer Patient.  The Beaumont Cancer Institute and its Breast Program treat […]

Learn More

How Much Is Too Much ?

Published On: |Eric Brown

Breast cancer treatment options are quite extensive.  In a recent publication in the Journal of General Internal Medicine (J Gen Intern Med 28:630-636), 368 women at 8 NYC hospitals were questioned about the amount of information they received during decision  making for their early stage breast cancer.  Too much perceived responsibility for breast cancer treatment […]

Learn More

Male Breast Cancer

Published On: |Kylie Chin

That’s not a typo—breast cancer can and does occur in men but it’s rare. In fact, it occurs in less than 1% of all breast cancer cases, so most people don’t even realize that the disease affects more than just women. According to cancer researchers, it’s estimated that in 2014 there will be 2,360 new […]

Learn More

New Pre-Surgical (Neoadjuvant) Breast Cancer Drug is on the Road to Approval

Published On: |Kylie Chin

Roche, a Swiss global health-care company, has recently received a positive review from the Food and Drug Administration (FDA) concerning their new pre-surgical breast cancer treatment drug, Perjeta. In actuality, a positive review is an understatement. FDA scientists are recommending accelerating the approval process for the drug, a measure usually reserved for pioneering drugs that […]

Learn More

The Survival Rate Racial Disparity Persists

Published On: |Kylie Chin

Black women in the United States are 40 percent more likely to die of breast cancer than white women according to a study published in the July 24/31 issue of the Journal of the American Medical Association. In fact, breast cancer survival rates for black women diagnosed in last two decades has not changed one […]

Learn More

Metastatic Breast Cancer on the Rise Among Young Women

Published On: |Kylie Chin

A new study conducted by researchers at the University of Washington, Seattle and St. Charles Health System in Bend, Ore., has revealed the percentage of young women in the U.S. who have advanced breast cancer has moderately increased in the last 35 years. Researchers studied the frequency of metastatic breast cancer (cancer that has spread […]

Learn More